
Making Lab Automation Actually Work
Manual experiment monitoring and data capture is still the status quo in most biotech and pharma labs, compromising efficiency and project timescales. But there is a better way.

Manual experiment monitoring and data capture is still the status quo in most biotech and pharma labs, compromising efficiency and project timescales. But there is a better way.

The Spanish computational chemistry start-up Nextmol (Bytelab Solutions), a spin-off from the Barcelona Supercomputing Centre, offers a software-as-a-service (SaaS) platform that accelerates research and innovation in sustainable specialty chemicals through “in silico” experiments using molecular modeling and artificial intelligence (AI).

The Covid pandemic and its repercussions have changed the pharmaceutical industry and the healthcare markets. Richard Stedman, the CEO of ACG Engineering, discusses the lessons learned from the global supply chain disruptions and how innovative equipment helps pharma manufacturers overcome the challenges.

In response to the urgent need for sustainable solutions in the surfactants industry, companies like Locus Ingredients are developing environmentally friendly biosurfactants.

In the dynamic realm of the chemical industry, surfactants serve as indispensable components with versatile applications, particularly in the home and personal care sector.

In this interview, Christene Smith sits down with Anne Lamp, the CEO & Co-Founder of Traceless Materials, to delve into the groundbreaking world of natural biopolymer materials.

Interview with Alban Chesneau and Nicolas Castet, Carbon Waters


Johnson Matthey (JM) looks back at a legacy of 200+ years. Established in 1817, the London, England-based chemical company reported annual revenues of about €18 billion in 2022. JM has built a global presence with operations in more than 30 countries. The company’s strategy is based on the vision for a cleaner, healthier world and mirrors society’s need to create a more sustainable future. JM has set out to catalyze the net zero transition by delivering sustainable solutions to customers enabled by innovative technology and leading positions in JM’s key markets automotive, chemicals, and energy. To get a better understanding of the role JM’s technological developments play for a sustainable future, Michael Reubold spoke with Maurits van Tol, the company’s Chief Technology Officer.

Interview with Klaus-Peter Jung, Partner at the Miebach Consulting Group

Interview with Klara Yoon, Tina Rose and Stephan Enthaler, New Dawn

Interview with Fajer Mushtaq and Silvan Staufert, Oxyle

In this interview, Jinling Chen, head of WuXi STA’s drug product business, and Jamie Andrews, site head of WuXi STA’s Couvet facility, explain the company’s strategy and the goals of the European expansion.

Actylis, leading global manufacturer and sourcing expert of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, made its debut in September 2022. The new CDMO was created from US-based fine and specialty chemicals distributor Aceto. Gilles Cottier, CEO of Actylis, has played a tremendous role in Aceto’s transformation into the new Actylis brand. Ralf Kempf and Michael Reubold asked Cottier about the reasons for creating the new brand identity, the challenges of combining so many companies, and Actylis' strategy going forward.

Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.

CH-Bioforce, based in Raisio, Finland, strives for a cleaner world.

Traditional batch chemistry is too inefficient for a sustainable future. Switching batch processing to continuous processing is inevitable if the world is to reach net zero.

For decades, Ferrate(VI) has been known as the strongest oxidant in the world for the treatment of (industrial) wastewater.

Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and Cinven.

Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.

Dorothee Arns, Director General of FECC, discusses current challenges, market trends and her vision for the chemical distribution industry in Europe. The interview was conducted by Michael Reubold and Ralf Kempf.

Interview with Joachim Haupt and Florian Kaiser, PharmAI



In his interview with CHEManager, Jeff Zhu, chairman of the Chinese Association of International Chemical Manufacturers (AICM), talks about the industry’s role in helping achieve China’s carbon-neutrality goal.


Interview with Oliver Reimann and Andreas Regnery, Belyntic

Biovox was founded in 2020 to enable more sustainability through renewable bioplastics even in difficult applications such as consumables in healthcare or machine parts.

Interview with Jere Koskinen and Ali Harlin, Mega Cellulose.

B4Plastics is a Belgium-based biotechnology start-up and a polymer architecture company looking to catalyze the introduction of novel biomaterials and growing them from niche to bulk applications.

Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies.

In his interview with CHEManager, Thorsten Wenzel, Vice President and global head of the industry business unit Chemicals at SAP, talks about most recent trends and developments shaping the future of the chemical industry.

Industry experts Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 group – talk about the idea behind ISPE’s Pharma 4.0 initiative and the challenges on the way to realize the digital transformation of the pharmaceutical industry.

In his interview with CHEManager, Hidde van der Wal, CEO of chemical distributor Barentz, talks about the company’s performance in 2020 and latest strategic developments.

In the drive to reach growth objectives, or to maintain and enhance “critical mass”, mergers & acquisitions (M&A) has been a theme for the chemical distribution industry for years. The industry leaders (by size and geographic reach) were all built through a series of such transactions. The practice is further trickling down to the smaller and mid-sized company layer of the sector, and more distributors espouse external growth options.






































